Biotech Arcutis to Host Investor Conference Call Today to Discuss the FDA Approval of ZORYVE(TM) (roflumilast) Cream 0.3% for Plaque Psoriasis August 1, 2022
Biotech REGENXBIO to Host Conference Call on August 3 to Discuss Second Quarter 2022 Financial Results and Recent Operational Highlights August 1, 2022
Biotech Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast July 25, 2022
Biotech Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease Mouse Model July 25, 2022
Biotech Arcutis Biotherapeutics Reaches Regulatory Milestone with Health Canada Acceptance of New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis July 25, 2022
Biotech Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery July 25, 2022
Biotech Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules July 25, 2022
Biotech Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 25, 2022
Search
Biotech
August 1, 2022
August 1, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
